Elevated plasma homocysteine has been linked to pregnancy complications and developmental diseases. Whereas hyperhomocysteinemia is frequently observed in populations at risk of malnutrition, hypoxia may alter the remethylation of homocysteine in hepatocytes. We aimed to investigate the combined influences of early deficiency in nutritional determinants of hyperhomocysteinemia and of neonatal hypoxia on homocysteine metabolic pathways in developing rats. Dams were fed a standard diet or a diet deficient in vitamins B12, B2, folate, month, and choline from 1 mo before pregnancy until weaning of the offspring. The pups were divided into four treatment groups corresponding to "no hypoxia/standard diet," "hypoxia (100% N2 for 5 min at postnatal d 1)/standard diet," "no hypoxia/ deficiency," and "hypoxia/deficiency," and homocysteine metabolism was analyzed in their liver at postnatal d 21. Hypoxia increased plasma homocysteine in deficient pups (21.2 Ϯ 1.6 versus 13.3 Ϯ 1.2 M, p Ͻ 0.05). Whereas mRNA levels of cystathionine -synthase remained unaltered, deficiency reduced the enzyme activity (48.7 Ϯ 2.9 versus 83.6 Ϯ 6.3 nmol/h/mg, p Ͻ 0.01), an effect potentiated by hypoxia (29.4 Ϯ 4.7 nmol/h/mg, p Ͻ 0.05). The decrease in methylene-tetrahydrofolate reductase activity measured in deficient pups was attenuated by hypoxia (p Ͻ 0.05), and methionine-adenosyltransferase activity was slightly reduced only in the "hypoxia/deficiency" group (p Ͻ 0.05). Finally, hypoxia enhanced the deficiency-induced drop of the S-adenosylmethionine/S-adenosylhomocysteine ratio, which is known to influence DNA methylation and gene expression. In conclusion, neonatal hypoxia may increase homocysteinemia mainly by decreasing homocysteine transsulfuration in developing rats under methyl-deficient regimen. Plasma accumulation of HCY is known to be linked to cardiovascular diseases and ageing-associated disabilities (1-3). Moderate hHCY can arise from genetic determinants (4,5) but is also frequently related to dietary deficiency in vitamins B12, B2, and folate. In newborns, the risk of hHCY is closely related to elevated maternal HCY concentrations during pregnancy, which is determined by the status of B vitamins (6 -8).A strong relationship has been documented between HCY accumulation and pregnancy complications, including recurrent miscarriages, preeclampsia, and placenta abruption (see Ref. 9 for review). In the progeny, hHCY has been associated with fetal death (10), premature birth (11), intrauterine growth retardation (12), neural tube defects (13), craniofacial anomalies (14), cardiac malformation (15), and hepatic steatosis (16).HCY production involves the demethylation of methionine, and, under normal conditions, is essentially regulated in the liver. As summarized in Figure 1, it originates from the hydrolysis of SAH, a product of transmethylation reactions through SAM, and is metabolized via two pathways of remethylation and one pathway of transsulfuration. HCY metabolism strongly depends on the nutritional intake of B vitamins,